QSI
Quantum-Si incorporated
NASDAQ · Healthcare · Biotechnology · US
$0.77
+1.56%Aug 14, 2026, 03:04 UTC
Quantum-Si announced a targeted workforce reduction of about 20% to lower cash burn and fund the revised development timeline.
Source:Aug 14, 2026, 03:04 UTC
Quantum-Si moved the planned launch of its Proteus protein sequencing platform to Q2 2027 from end of 2026, citing the need for an additional integrated instrument design cycle before production.
Source:Aug 13, 2026, 23:51 UTC
Quantum-Si Incorporated reported a Q2 loss of $0.11 per share, beating the Zacks Consensus Estimate of a $0.13 loss and improving from a $0.16 loss a year ago.
Jun 24, 2026, 00:00 UTC
Quantum-Si Inc signed a 120-month commercial lease for 54,374 square feet of office, laboratory and manufacturing space in San Diego, California to support its Proteus platform development and expanded manufacturing.